Fortress Biotech (FBIO) Finished Goods (2020 - 2025)

Fortress Biotech's Finished Goods history runs 6 years deep, the most recent figure standing at $10.0 million for Q1 2025.

• In Q1 2025, Finished Goods rose 70.95% year-over-year to $10.0 million; the TTM figure through Mar 2025 stood at $10.0 million (up 70.95% YoY), while the FY2024 annual figure was $11.4 million, up 128.21% from the prior year.
• Finished Goods for Q1 2025 stood at $10.0 million, down from $11.4 million in the prior quarter.
• The five-year high for Finished Goods was $11.4 million in Q4 2024, with the low at $4.3 million in Q4 2021.
• The 5-year median for Finished Goods is $7.1 million (2023), against an average of $7.3 million.
• The sharpest annual moves came in 2021 and 2023: Finished Goods surged 205.56% in 2021, then slumped 35.56% in 2023.
• Fortress Biotech's Finished Goods stood at $4.3 million in 2021, then soared by 80.4% to $7.7 million in 2022, then slumped by 35.56% to $5.0 million in 2023, then soared by 128.21% to $11.4 million in 2024, then slipped by 11.91% to $10.0 million in 2025.
• Business Quant data shows FBIO's Finished Goods at $10.0 million in Q1 2025, $11.4 million in Q4 2024, and $8.7 million in Q3 2024.